Alan P. Lyss, MD

Studies suggest that ctDNA testing has prognostic value in colorectal cancer, but more research is needed before it can be used in practice.

As many as 10% of early-onset metastatic colorectal cancer cases may be attributable to undiagnosed inflammatory bowel disease, a study suggests.

A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.

New research suggests aspirin may lower the risk for gastric adenocarcinoma in women but not in men.